Excision

Excision BioTherapeutics is a biotechnology company developing CRISPR-based therapies for viral diseases, including HIV, HSV, and HBV

excision.bio

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Excision BioTherapeutics is a biotechnology company developing CRISPR-based therapies for viral diseases, including HIV, HSV, and HBV. It uses gene editing to excise viral DNA.

02Backed By5 investors

AVArtis Ventures→CVCivilization Ventures→AV

Is this your company? Claim your profile

Abstract Ventures

→

GVGreatPoint Ventures→

OTOlive Tree Capital→

03Similar Companies

VB

Vir Biotechnology

Biotech & Life Sciences

→

EM

Editas Medicine

Biotech & Life Sciences

→

RT

Replay Therapeutics

Biotech & Life Sciences

→

PB

Precision Biosciences

Biotech & Life Sciences

→

HM

Homology Medicines

Biotech & Life Sciences

→

04Startup DNA

9

signals

Sectors
Business Model
Technology